CEVA Logistics launches new sub-brand FORPATIENTS in healthcare logistics

• The company is also introducing a new temperature-sensitive logistics product that will begin service in the second quarter of 2021.
  

April 08, 2021: In an expansion of its support for global healthcare and pharmaceutical customers, CEVA Logistics launched a new sub-brand CEVA FORPATIENTS to support better patient outcomes through the company’s broad range of healthcare logistics services. 

As part of the suite of solutions, the company is also introducing a new temperature-sensitive logistics product that will begin service in the second quarter of 2021.

The CEVA FORPATIENTS suite of healthcare logistics now encompasses temperature-sensitive solutions, pharma and biopharma, medical devices, consumer health, hospital and home care, as well as diagnostic and laboratory services. 

In view of better patient outcomes, CEVA’s healthcare solutions address quality, privacy and compliance requirements, including being fully GxP and GDP compliant and meeting all national and international regulatory requirements. The company ensures these areas are managed from pick-up to delivery. 

The new CEVA Logistics’ solution requires investment in temperature-controlled facilities around the world. With the support of its parent company, the CMA CGM Group, CEVA has committed to operating a network of more than 40 such airfreight stations by the end of 2021. Some of the stations will also offer other services, such as contract logistics support.

Niels Van Namen, executive vice president of CEVA’s global healthcare sector, said, “Our customers’ supply the vaccines, medical devices, medication and other support products on which patients around the world depend. For example, diabetic patients should not have to worry about supply chain reliability for their insulin. At CEVA, we’re expanding our temperature-sensitive solutions to ensure that, no matter the logistics challenges faced, patients’ needs are met. Behind every shipment, we see a patient.”

In all, the stations will allow CEVA to not only service major healthcare gateways in regional markets, but also to supply more than 1,450 healthcare trade lanes globally. Through the global network, CEVA will welcome a broad range of customer shipments in conjunction with its temperature-sensitive packaging solutions, including active and passive packaging, as well as solutions for out-of-gauge goods.

As part of its product offerings, CEVA will provide leading visibility and monitoring solutions for real-time decisions through embedded location and temperature IoT devices. Information will flow into the company’s Matrix supply chain management tool, as well as its global control tower technology for 24x7 shipment monitoring. With vaccine and medicine transport growing globally, CEVA will focus its efforts on the 2- to 8-degree Celsius spectrum of products, including certain Covid-19 vaccines.